Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms

Table 1 Demographic, clinical and treatment characteristics

	WC	BD-	BD+	P-value
	(n = 23)	(n = 23)	(n = 22)
	Mean (SD) or n (%)	Mean (SD) or n (%)	Mean (SD) or n (%)
Female sex	12 (52.2)	13 (56.5)	12 (54.5)	0.957^a
Age (years)	31.65 (5.21)	34.61 (7.28)	36.86 (7.03)	0.034^b
Age at onset (years)		22.13 (6.37)	21.64 (6.21)	0.793^c
Onset episode (mania/depression)		15 (65.2) / 8 (34.8)	11 (50) / 11 (50)	0.302^a
Duration of illness (years)		12.48 (7.23)	15.23 (7.65)	0.222^c
Total number of episodes		4.69 (3.08)	8.95 (6.21)	0.005^c
Mania		2.96 (2.14)	4.09(4.62)	0.293^c
Depression		1.13 (1.79)	3.45 (2.70)	0.001^c
Mixed		0.09 (0.29)	0.45 (1.22)	0.168^c
Total number of episodes per year		0.35 (0.17)	0.55 (0.23)	0.001^c
Family history of mood disorder		10 (43.5)	10 (45.5)	0.894^a
Treatment modality				0.006^a
MS		9 (39.13)	1 (4.55)
MS + AP		12 (52.17)	13 (59.09)
MS + AD		2 (8.70)	2 (9.09)
MS + AP + AD		0	6 (27.27)
Duration of ongoing subsyndromal symptoms (months)			4.95 (3.43)
Subtype of ongoing subsyndromal symptoms (depressive/manic/mixed)			14/6/2

WC: well controls, BD-: euthymic bipolar patients without subsyndromal symptoms, BD+: euthymic bipolar patients with subsyndromal symptoms, MS: Mood stabilizer, AP: Antipsychotic, AD: Antidepressant.
^aChi square.
^bOne-way ANOVA.
^ct test.

ISSN: 1471-244X